Dr. Agarwal's Healthcare IPO - Day 3 Subscription at 0.45 Times

resr 5paisa Research Team

Last Updated: 3rd February 2025 - 03:58 pm

Listen icon

Dr. Agarwal's Healthcare's initial public offering (IPO) has shown notable improvement in its final day of bidding, reaching a subscription rate of 0.45 times by 10:59:51 AM on day three. The ₹3,027.26 crore offering has demonstrated progressive growth from 0.07 times on day one and 0.42 times on day two, highlighting increasing investor interest particularly in the institutional segment.
 

 

Dr. Agarwal's Healthcare's IPO has attracted Qualified Institutional Investor’s attention, and these QIBs have subscribed 1.01 times. The retail segment has increased to 0.28 times, while Non-Institutional Investors have reached 0.16 times subscription. Small NIIs continue to show relatively stronger interest at 0.25 times compared to large NIIs at 0.11 times.

Subscription Status of Dr. Agarwal's Healthcare IPO:

Date QIB NII  Retail Employee Others Total
Day 1 (Jan 29) 0.00 0.06 0.12 0.09 0.14 0.07
Day 2 (Jan 30) 1.01 0.12 0.24 0.17 0.25 0.42
Day 3 (Jan 31)* 1.01 0.16 0.28 0.20 0.29 0.45

*As of 10:59:51 AM

Here are the subscription details for Dr. Agarwal's Healthcare IPO as of Day 3 (31st January 2025, 10:59:51 AM):

Investor Category Subscription (times) Shares Offered Shares bid for Total Amount (Rs Cr.)
Anchor Investors 1.00 2,17,78,798 2,17,78,798 875.508
Qualified Institutions 0.00 1,45,19,200 1,45,19,200 591.273
Non-Institutional Buyers 0.16 1,08,89,400 17,15,665 68.970
- bNII (bids above ₹10L) 0.11 72,59,600 7,94,605 31.943
- sNII (bids below ₹10L) 0.25 36,29,800 8,96,735 36.049
Retail Investors 0.28 2,54,08,599 71,76,400 288.491
Employees 0.20 15,79,399 3,12,025 12.543
Others 0.29 11,29,574 3,32,185 13.354
Total 0.45 1,55,12,978 2,42,44,570 974.632

Note:

"Shares Offered" and "Total Amount" are calculated based on the upper price of the issue price range.
The portions of anchor investors and market maker are not included in the total shares offered.

Key Highlights - Day 3:

  • Overall subscription reached 0.45 times by final morning
  • QIB portion fully subscribed at 1.01 times
  • Retail investors advanced to 0.28 times subscription
  • Small NIIs showing consistent interest at 0.25 times
  • Employee portion reaching 0.20 times
  • Shareholder category at 0.29 times
  • Total bids worth ₹974.632 crores received
  • Applications increased to 2,14,157
  • Institutional participation notably strengthened
  • Balanced participation across categories

 

Dr. Agarwal's Healthcare IPO - Day 2 Subscription at 0.42 Times

Key Highlights:

  • Overall subscription improved to 0.42 times
  • QIB portion saw strong uptake reaching 1.01 times
  • Retail investors progressed to 0.24 times
  • Small NIIs reached 0.20 times subscription
  • Employee portion advanced to 0.17 times
  • Shareholder category achieved 0.25 times
  • Steady growth across investor categories
  • Institutional momentum building

 

Dr. Agarwal's Healthcare IPO - Day 1 Subscription at 0.07 Times

Key Highlights:

  • Overall subscription began at 0.07 times
  • Retail investors started at 0.12 times
  • Small NIIs opened at 0.09 times
  • Employee portion initiated at 0.09 times
  • Shareholder category began at 0.14 times
  • Measured start with gradual participation
  • Early interest from retail segment
  • Foundation set for subsequent days

 

About Dr. Agarwal's Health Care Limited

Incorporated in 2010, Dr. Agarwal's Health Care Limited has established itself as India's largest eye care services provider, offering comprehensive ophthalmological care through an extensive network of facilities. The company has developed a sophisticated hub-and-spoke operating model that encompasses 28 hub facilities (including three Centers of Excellence) and 165 spoke facilities, comprising 53 primary and 112 secondary care centers as of September 30, 2024.

The company's service portfolio spans the complete spectrum of eye care, from basic consultations to advanced surgical procedures. Their expertise includes cataract surgeries utilizing cutting-edge techniques such as robotic surgery and phacoemulsification, refractive surgeries including LASIK and SMILE, and various other specialized eye procedures. The company's commitment to clinical excellence is reflected in their impressive patient care statistics, having served 2.13 million patients and performed 220,523 surgeries during the six months ending September 30, 2024.

Their geographical footprint extends across 117 cities in India, covering 14 states and four union territories through 193 facilities. This extensive network is supported by 737 doctors who provide specialized eye care services. The company's financial performance demonstrates steady growth, with revenue of ₹837.94 crores and profit after tax of ₹39.56 crores for the period ended September 30, 2024, underlining their significant presence in India's healthcare sector.
 

Highlights of the Dr. Agarwal's Healthcare IPO:

  • IPO type: Book Built Issue IPO
  • IPO size: ₹3,027.26 crores
  • Fresh Issue: ₹300.00 crores (74.63 lakh shares)
  • Offer for Sale: ₹2,727.26 crores (6.78 crore shares)
  • Face value: ₹1 per share
  • Price band: ₹382 to ₹402 per share
  • Lot size: 35 shares
  • Minimum investment for retail investors: ₹14,070
  • Minimum investment for small NII: ₹2,11,050 (15 lots)
  • Minimum investment for big NII: ₹10,13,040 (72 lots)
  • Employee reservation: 15,79,399 shares
  • Listing at: BSE, NSE
  • IPO opens: 29th January 2025
  • IPO closes: 31st January 2025
  • Allotment date: 3rd February 2025
  • Refund initiation: 4th February 2025
  • Credit of shares: 4th February 2025
  • Listing date: 4th February 2025
  • Lead Managers: Kotak Mahindra Capital Company Limited, Morgan Stanley India Company Pvt Ltd, Jefferies India Private Limited, Motilal Oswal Investment Advisors Limited
  • Registrar: Kfin Technologies Limited

 

FREE Trading & Demat Account
Open FREE Demat Account with endless opportunities.
  • Flat ₹20 Brokerage
  • Next-gen Trading
  • Advance Charting
  • Actionable Ideas
+91
''
By proceeding, you agree to our T&Cs*
Mobile No. belongs to
hero_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form